$PFE Recent Headlines Updates, advisories and surprises

New Post Public Reply Private Reply Replies (0) Message Board

Jan 29, 2014 at 1:22 PM

$PFE Recent Headlines

Updates, advisories and surprises 5:31 p.m. Jan. 28, 2014 - MarketWatch
U.S. stocks rise; Dow breaks 5-day skid 5:02 p.m. Jan. 28, 2014 - Anora Mahmudova
Stocks rebound, helping Dow quit loss streak; Yahoo drops after hours (Stock market live blog recap) 4:31 p.m. Jan. 28, 2014 - blogs.marketwatch.com
Newscast: Stocks back in the win column 4:27 p.m. Jan. 28, 2014 - MarketWatch
Apple sees worst day in a year; Casablanca lifts Cliffs 3:10 p.m. Jan. 28, 2014 - Ben Eisen
Pfizer beats views, even as fourth-quarter sales and earnings slide 12:28 p.m. Jan. 28, 2014 - blogs.marketwatch.com
U.S. stocks rebound on Ford, DuPont; Apple falls 9:37 a.m. Jan. 28, 2014 - Laura Mandaro
Ford shares rise 1%; Pfizer gains 2.6% 9:33 a.m. Jan. 28, 2014 - Laura Mandaro
U.S. stock futures pare gains; Apple weighs on tech 9:19 a.m. Jan. 28, 2014 - Barbara Kollmeyer
Apple's beating, TPDH and America's 'false dawn' recovery 9:17 a.m. Jan. 28, 2014 - blogs.marketwatch.com
Newscast: Fed policymakers gather in Washington 7:30 a.m. Jan. 28, 2014 - MarketWatch
Pfizer profit hurt by generics competition 7:23 a.m. Jan. 28, 2014 - MarketWatch.com
Pfizer shares rise after earnings beat 7:18 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer shares rise 2% premarket 7:10 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer sees 2014 adj. sales of $49.2B to $51.2B 7:09 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer sees 2014 adj. EPS of $2.20 to $2.30 7:08 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer Q4 EPS $0.39; Adj. EPS $0.56 7:07 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer Q4 profit falls 59% to $2.57 billion 7:07 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Pfizer Q4 sales down 2% to $13.56 billion 7:06 a.m. Jan. 28, 2014 - Saumya Vaishampayan
Apple, Ford, Yahoo are Tuesday’s stocks to watch 6:56 a.m. Jan. 28, 2014 - Sue Chang

Another Strong Earnings Beat from Amgen - Analyst Blog 11:30 a.m. Today - Zacks.com
Stock Market News for January 29, 2014 - Market News 10:06 a.m. Today - Zacks.com
Top Analyst Upgrades and Downgrades: American Airlines, EA, Teradata, VMware, Walmart and More 8:09 a.m. Today - 247WallSt.com
Pfizer Inc. (PFE): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Today - Zacks.com
'Mad Money' Lightning Round: Sell, Sell, Sell Windstream 6:00 a.m. Today - TheStreet.com
Cramer's Lightning Round - Agilent Is Sensational (1/28/14) 5:16 a.m. Today - Seeking Alpha
Don't Underestimate Amgen: Part 2A, Cardiovascular And Oncology Pipeline Products 3:01 a.m. Today - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Where Have All the Sellers Gone? 8:34 p.m. Jan. 28, 2014 - TheStreet.com
Bitter Medicine in Store for Activists 8:13 p.m. Jan. 28, 2014 - WSJ.com
Bayer's Aleve May Have Lower Cardiac Risk Than Rival Painkillers 7:20 p.m. Jan. 28, 2014 - WSJ.com
Pfizer's CEO Discusses Q4 2013 Results - Earnings Call Transcript 5:04 p.m. Jan. 28, 2014 - Seeking Alpha
The 4 Stocks That Dominated the Market on Tuesday 4:02 p.m. Jan. 28, 2014 - 247WallSt.com
Pfizer coy about split/spinoff plans 2:44 p.m. Jan. 28, 2014 - Seeking Alpha
Pfizer Upbeat About Breast-Cancer Drug, Pneumonia Vaccine 2:29 p.m. Jan. 28, 2014 - WSJ.com
Buybacks Instead of Capital Investment - Ahead of Wall Street 10:24 a.m. Jan. 28, 2014 - Zacks.com
Dow Today: Pfizer (PFE) Leads The Day Higher, Home Depot (HD) Lags 10:00 a.m. Jan. 28, 2014 - TheStreet.com
Pfizer Tops on Earnings & Revs, Guides In-Line - Analyst Blog 9:57 a.m. Jan. 28, 2014 - Zacks.com
Pfizer: Bad Quarter, Good Year, Better Outlook 9:35 a.m. Jan. 28, 2014 - Wall St. Cheat Sheet
Stocks Climb Amid Emerging-Market Optimism 7:38 a.m. Jan. 28, 2014 - FOXBusiness
Pfizer Stock Floats on Financial Engineering, Not Growth 5:39 a.m. Jan. 28, 2014 - InvestorPlace.com

Pfizer Reports Fourth-Quarter and Full-Year 2013 Results;Provides 2014 Financial Guidance 7:01 a.m. Jan. 28, 2014 - BusinessWire - BZX
Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer 7:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
Pfizer Reports Top-Line Results From ALO-02 Phase 3 Study 8:00 a.m. Jan. 23, 2014 - BusinessWire - BZX
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
New Survey Reveals What Match.Com Members Think About Smoking Cigarettes And Dating 10:00 a.m. Jan. 22, 2014 - BusinessWire - BZX
Lpath Granted Key U.S. Patent Related to Ocular Drug Program, iSONEP 7:30 a.m. Jan. 22, 2014 - PR Newswire - PRF
CHANTIX®/CHAMPIX® (varenicline) Demonstrates Smoking-Cessation Efficacy In Smokers Unwilling or Unable To Quit Abruptly 8:00 a.m. Jan. 21, 2014 - BusinessWire - BZX
ViiV Healthcare's new HIV medicine Tivicay™ (dolutegravir) is approved in Europe 6:52 a.m. Jan. 21, 2014 - PR Newswire - PRF
Statement from Pfizer Chief Medical Officer on the 50th Anniversary of the First Surgeon General's Report on Smoking and Health 10:15 a.m. Jan. 17, 2014 - BusinessWire - BZX
Collaborations, Conference Participation Schedules, and Upcoming Earnings Release - Research Report on Pfizer, Humana, WellPoint, Stryker, and Centene 8:00 a.m. Jan. 14, 2014 - PR Newswire - PRF
Companies Aligned to Capitalize on New Japanese Regenerative Medicine Initiatives 10:09 a.m. Jan. 13, 2014 - ACCESSWIRE
Portola Pharmaceuticals Enters Second Clinical Collaboration Agreement With Bristol-Myers Squibb and Pfizer to Study Andexanet Alfa* (PRT4445), Investigational Factor Xa Inhibitor Reversal Agent, With Eliquis 8:00 a.m. Jan. 13, 2014 - GlobeNewswire
Avillion Group Partners with Pfizer to Co-develop BOSULIF® (bosutinib) as First-Line Treatment for Patients with Chronic Myelogenous Leukemia 8:47 a.m. Jan. 9, 2014 - PR Newswire
Akili Interactive Labs Announces Partnership with Pfizer to Test Video Game in People at Risk of Alzheimer's Disease 8:03 a.m. Jan. 9, 2014 - PR Newswire
Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix 8:00 a.m. Jan. 8, 2014 - PR Newswire
Nodality Enters into a Strategic Collaboration with Johnson & Johnson Innovation in Autoimmune Diseases 7:59 a.m. Jan. 8, 2014 - BusinessWire
Clinical Studies and Financial Results - Research Report on Pfizer, United Therapeutics, Insys, Puma Biotechnology, and Acorda 8:00 a.m. Jan. 1, 2014 - PR Newswire
Senesco Announces Letter of Intent to Merge with Fabrus 9:38 a.m. Dec. 30, 2013 - BusinessWire
Senesco Announces Letter of Intent to Merge with Fabrus 8:52 a.m. Dec. 30, 2013 - BusinessWire
Regulatory Submissions, New Clinical Trials, Results Scheduled, and Conference Calls - Research Report on Pfizer, Novartis, Teva, Universal Health Services, and BD 8:00 a.m. Dec. 24, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Donatos Targets Texas: Pushing Franchise Growth Limits

Donatos Pizza: Ambitious Expansion in the Lone Star State When you think about pizza chains expanding, Donatos Pizza might not be the first name to come to mind, but they're cooking up something big in Texas. Folks in Dallas and Houston better be ready because Donatos is rolling out the red carpet for its edge-to-edge, topping-loaded pies all over Texas. Strategic Growth:...

Chad Tucker's Sequel Explores Deep Spiritual Themes

An Honest Take: Faith, Growth, and Surrender A player in the world of spiritual growth literature has stepped up again, and it ain't holding back. Chad Tucker, a name perhaps familiar to folks following transformation tales soaked with faith, has released a beefy sequel to his first hit: The Lord in Us: If You Can Love an Enemy, You Can Love Anyone. Well, now he's back...

Airswift's Strategic Acquisition Boosts U.S. Energy Presence

What's Driving Airswift's Latest Expansion? Airswift just dropped a bombshell by snapping up key businesses from New Tech Global (NTG), marking a serious power move in the U.S. energy sector. Now, what does this actually mean for investors? In blunt terms: they're muscling up their contractor base by a meaty 30%. That's no small feat. It's a calculated step to ace the...

Omneky Integrates AI Growth Agent With Slack for Ads

Omneky's New Move: AI Growth Agent Meets Slack Picture this: You've got a marketing team hustling in the digital age, and now they've got a new ally. Omneky, the big-wig in autonomous AI growth, has snuck its AI Growth Agent right into Slack. This isn't just a party trick during Dreamforce week in San Francisco. This is Omneky throwing another cog into the advertising...

Guaranteed Roof Expands with EM Exteriors through LB Capital

A Bold Move to Elevate Roofing Standards In a move that seems to jolt the roofing industry awake, Guaranteed Roof is taking the wraps off its new strategic partnership with LB Capital and EM Exteriors. Think of it as a power trio aiming to redefine what roofing solutions should mean in the Southeast. It’s the kind of news that makes you sit up and ask, why now and why...

Piedmont Orthopedics Expands Care in Henry County

A Surgeon's Story Comes to Henry County Ah, the medical field. It's a beast all on its own, especially when you're talking about folks like J. Hunter Matthews, M.D. making waves in the orthopedic world. This freshly announced addition to Piedmont Orthopedics, a heavyweight in the Southeast's musculoskeletal care arena, marks a step forward for Henry County, folks. We're...

Linkind's Light Stick Revolutionizes Retail Lighting Experience

Transforming Lighting in Retail Spaces Folks, let's talk lighting. Not the humdrum switch-you-on kind, but something much snazzier, more customized, and downright interactive. I'm talking about Linkind's latest brainchild—the Smart Light Stick. Launched amidst the neon rush of tm:rw in New York City, this gizmo isn't just another bulb in the home improvement aisle. It's...

Metriport Eyes Major Step in Health Data Integration

Metriport's Push into the TEFCA Framework Son of a gun, Metriport's making noise in the health data world! They just got the nod as a Candidate QHIN under the Trusted Exchange Framework and Common Agreement, or TEFCA if you're into acronyms. This isn't just some digital high-five; it's a significant stride forward for healthcare data exchange. Now they're smack in the...

Foodcare Proves Effective in Reducing Blood Sugar Levels

A New Chapter for Diabetes Care: Foodcare Folks, we've got ourselves a game-changer in the world of diabetes care. Listen closely: Foodsmart's latest study, hot off the press from the American Heart Association's Circulation, essentially hands over the blueprint for tackling type 2 diabetes in an innovative fashion. Now, I'm not the type to get all mushy over scientific...

Beetles Gel Polish Unveils Vibrant Fall Nail Carnival

Beetles Gel Polish Launches Fall Nail Carnival Here comes a new twist on fall fashion, and no, it ain’t your grandma's knitted sweater. We're talking nail polish—a vibrant, flashy ordeal brought to you by Beetles Gel Polish with their Fall Nail Carnival. They're rolling out this spectacle not just for your visions of grandeur nail ideas, but for those seeking deals...